LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

Home・Aandelen Lijst・Thermo Fisher Scientific Inc
Search

Thermo Fisher Scientific Inc

Gesloten

SectorGezondheidszorg

466.62 0.92

Strong Buy

Prijsupdate 5 mei 2026, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

459.78

Max

471.21

Belangrijke statistieken

By Trading Economics

Inkomsten

-314M

1.7B

Verkoop

-1.2B

11B

K/W

Sectorgemiddelde

25.772

49.8

EPS

5.44

Dividendrendement

0.38

Winstmarge

15.048

Werknemers

125,000

EBITDA

-905M

2.3B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+34.17% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.38%

2.25%

Volgende Winsten

22 jul 2026

Volgende dividenddatum

14 jul 2026

Volgende Ex Dividend datum

12 jun 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-24B

172B

Vorige openingsprijs

465.7

Vorige sluitingsprijs

466.62

Nieuwssentiment

By Acuity

24%

76%

85 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

406.5 / 417.79 Steun & Weerstand

Thermo Fisher Scientific Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 apr 2026, 13:56 UTC

Winsten

Thermo Fisher Profit Up, Warns of Inflation from Iran War -- Update

DJ

Lezen

23 apr 2026, 10:28 UTC

Winsten

Thermo Fisher Posts Higher 1Q Profit, Revenue

DJ

Lezen

29 jan 2026, 11:34 UTC

Winsten

Thermo Fisher 4Q Profit Rises as Biopharma Spending Rebounds

DJ

Lezen

29 okt 2025, 10:51 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 billion

DJ

Lezen

23 okt 2025, 20:49 UTC

Winsten

Correction to Thermo Fisher Article on Oct. 22

DJ

Lezen

22 okt 2025, 10:28 UTC

Winsten

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

DJ

Lezen

23 apr 2026, 10:01 UTC

Winsten

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

DJ

Lezen

23 apr 2026, 10:01 UTC

Winsten

Thermo Fisher: Well Positioned to Deliver Strong Year >TMO

DJ

Lezen

23 apr 2026, 10:00 UTC

Winsten

Thermo Fisher 1Q Net $1.65B >TMO

DJ

Lezen

23 apr 2026, 10:00 UTC

Winsten

Thermo Fisher 1Q Adj EPS $5.44 >TMO

DJ

Lezen

23 apr 2026, 10:00 UTC

Winsten

Thermo Fisher 1Q EPS $4.43 >TMO

DJ

Lezen

23 apr 2026, 10:00 UTC

Winsten

Thermo Fisher 1Q Rev $11.01B >TMO

DJ

Lezen

24 mrt 2026, 12:04 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Completes Acquisition of Clario Holdings for $8.875 Billion >TMO

DJ

Lezen

24 mrt 2026, 12:00 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Scientific Completes Acquisition Of Clario Holdings, Inc. >TMO

DJ

Lezen

29 jan 2026, 11:01 UTC

Winsten

Thermo Fisher 4Q Organic Revenue Rose 3% >TMO

DJ

Lezen

29 jan 2026, 11:00 UTC

Winsten

Thermo Fisher: Entering 2026 From Position of Strength >TMO

DJ

Lezen

29 jan 2026, 11:00 UTC

Winsten

Thermo Fisher 4Q Net $1.96B >TMO

DJ

Lezen

29 jan 2026, 11:00 UTC

Winsten

Thermo Fisher 4Q Rev $12.22B >TMO

DJ

Lezen

29 jan 2026, 11:00 UTC

Winsten

Thermo Fisher 4Q EPS $5.21 >TMO

DJ

Lezen

29 jan 2026, 11:00 UTC

Winsten

Thermo Fisher 4Q Adj EPS $6.57 >TMO

DJ

Lezen

29 okt 2025, 10:06 UTC

Acquisities, Fusies, Overnames

Thermo Fisher: Clario Provides Endpoint Data Solutions for Clinical Trials >TMO

DJ

Lezen

29 okt 2025, 10:05 UTC

Acquisities, Fusies, Overnames

Thermo Fisher: Claro Deal Includes Potential Additional Earnout, Other Payments >TMO

DJ

Lezen

29 okt 2025, 10:05 UTC

Acquisities, Fusies, Overnames

Thermo Fisher to Buy Clario From Group Led by Astorg and Nordic Cap, Novo Holding, Cinven >TMO

DJ

Lezen

29 okt 2025, 10:04 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Scientific to Pay $8.875 Billion at Closing for Clario Holdings >TMO

DJ

Lezen

29 okt 2025, 10:00 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Scientific to Acquire Clario Holdings >TMO

DJ

Lezen

22 okt 2025, 10:01 UTC

Winsten

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

DJ

Lezen

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

DJ

Lezen

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Adj EPS $5.79 >TMO

DJ

Lezen

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Rev $11.12B >TMO

DJ

Lezen

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Net $1.62B >TMO

DJ

Lezen

Peer Vergelijking

Prijswijziging

Thermo Fisher Scientific Inc Prognose

Koersdoel

By TipRanks

34.17% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 620.69 USD  34.17%

Hoogste 685 USD

Laagste 560 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Thermo Fisher Scientific Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

14

Buy

1

Hold

0

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan Thermo Fisher Scientific Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

406.5 / 417.79Steun & Weerstand

Korte Termijn

Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

There is one bearish event.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

85 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

988.57

↑ +2.13%

JNJ

Johnson and Johnson

225.57

↑ +0.63%

ABBV

AbbVie Inc

206.03

↓-1.03%

UNH

UnitedHealth Group Inc

363.82

↓-1.87%

AZN

AstraZeneca PLC

181.33

↓-1.06%
help-icon Live chat